AKAN
Akanda Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$1.12
−6.67%Latest reported
- Last report date
- Dec 31, 2021
- EPS actual
- -$0.97
- EPS estimate
- —
- Revenue actual
- $24.1K
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Dec 31, 2021 | — | -$0.97 | — | $24.1K |
| Sep 30, 2021 | — | -$1.67 | — | $13.4K |
| Dec 31, 2020 | — | $0.21 | — | $274 |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Apr 29, 2026